top of page
Orange Biomed is a Healthcare Startup With Cutting-Edge Diabetes Management Technology.
blog
Diabetes Blog
news
Orange Biomed News
company updates
Orange Biomed Company Updates
Orange Biomed Established a Corporate R&D Center (2021)
Orange Biomed Raises Seed Funding from Institutional Investors (2021)
Orange Biomed Raises Pre-A Funding (2022)
Orange Biomed Secures Strategic Investment from Established Manufacturer (2022)
Orange Biomed Receives Government Grants for Prospective Biomedical Technology (2021)
Orange Biomed Completes Prototype Development (2022)
Orange Biomed Receives 1st Patent (2022)
The Korea Credit Guarantee Fund has approved a loan guarantee of 1.5 billion won, providing full coverage with a 100% ratio(2023)
Orange Biomed Signs a Clinical Trial Agreement with Seoul Asan Medical Center (2021)
Orange Biomed Completes 1st Clinical Trial with Seoul Asan Medical Center (2022)
Orange Biomed Files Comprehensive U.S. and International Patents (2022)
Orange BioMed Registers 5 Patents and Files 10 Patent Applications in U.S. and Globally (2024)
bottom of page